血必净治疗老年感染性休克的疗效观察  被引量:1

Clinical observation of Xuebijing in elderly septic shock

在线阅读下载全文

作  者:范亚霞[1] 刘文涛[1] 刘春景[1] 李丽[1] 李珊珊[1] 

机构地区:[1]河北联合大学附属医院,河北唐山063000

出  处:《医学美学美容(中旬刊)》2014年第11期124-125,共2页

摘  要:目的观察血必净治疗老年感染性休克的疗效,及其对患者APACHEⅡ评分和住院时间的影响。方法选取60例年龄〉60岁的感染性休克患者,随机分为对照组和治疗组,每组30例。两组均给予感染性休克常规治疗;治疗组加用血必净注射液50d,2次/d,连用7 d10观察并比较两组患者治疗后的病死率、疗效、APACHEⅡ评分和平均住院时间。计量资料以(X±s)表示,组问比较采用t检验;计数资料以率(%)表示,组间比较采用x2检验。结果对照组和治疗组死亡例数分别为12例(40 00%)和5例(16.67%);平均住院时间分别为(10.73±2.12)、(13.03±2.92)d;总有效率分别为53.3%和76.6%;治疗1周后APACHEⅡ总分分别为(14.27±2.73)和(10.20±1.91)分,两组比较差异均有统计学意义(均P〈0.05)。结论血必净作为一种辅助治疗老年感染性体克的药物,疗效确切,值得推广。Objective To explore the clinical effect of Xuebijing injection in elderly septic shock. Methods 60 cases patients, age 〉 60 years, with septic shk were randomly divided into treatment group and control group, each of 30 cases, Both groups received conventional treatment of septic shock. On the basis of conventional therapy, treatment group were given Xuebijing injection 50ml. After treatment, the deaths outcomes, APACHE Ⅱ score and average length of stay were compared. Measurement data to (plus or minus s) said, using t test is compared betweengroup; Count data to rate (%), said comparison betwean groups by chi -square test. Results the deaths of treatment group 5/30 (16.67%)was lower than that of control groupl2/30 (40. 00% ), The average hospitalization time was ( 10.73 ± 2.12), ( 13.03 ± 2.92) ;The Significant effective rate of treatment group and control group were 50% and 20% ,The total effective rate of tatment group and control group were76.6% and 53.3%. After treatment 7d, APACHE score of treatment group was lower than those of control group, the difference was statistica11y significant(P 〈0.05). Conclusion Xuebijing injection has a certain effect in the treatment of elderly septic shock

关 键 词:老年感染性休克 血必净 住院时间 APACHEⅡ评分 

分 类 号:R631[医药卫生—外科学]

 

参考文献:

正在载入数据...

 

二级参考文献:

正在载入数据...

 

耦合文献:

正在载入数据...

 

引证文献:

正在载入数据...

 

二级引证文献:

正在载入数据...

 

同被引文献:

正在载入数据...

 

相关期刊文献:

正在载入数据...

相关的主题
相关的作者对象
相关的机构对象